Editorial: Keeping the Body in Mind: Scientific Effort in Advocating the Best Outcomes for People Living With Severe Mental Illness

Front Endocrinol (Lausanne). 2022 Jan 3:12:831933. doi: 10.3389/fendo.2021.831933. eCollection 2021.

Katherine Samaras^{1

2

3}, David Shiers^{4

5

6}, Roger Chen^{1

2}, Richard I G Holt^{7

8}, Jackie Curtis^{9

10}

¹ Department of Endocrinology, St Vincent's Hospital, Sydney, NSW, Australia.
² St Vincent's Clinical School, University of New South Wales Sydney, Kensington, NSW, Australia.
³ Adipose Biology, Clinical Obesity and Nutrition Laboratory, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
⁴ Psychosis Research Unit, Greater Manchester Mental Health National Health Service (NHS) Trust, Manchester, United Kingdom.
⁵ Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom.
⁶ School of Medicine, University of Keele, Newcastle, United Kingdom.
⁷ Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
⁸ Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, United Kingdom.
⁹ Mindgardens Neuroscience Network, Sydney, NSW, Australia.
¹⁰ School of Psychiatry, University of New South Wales Sydney, Kensington, NSW, Australia.

No abstract available

Keywords: antipsychotic medication; cardiac disease; depression; diabetes; metabolism; obesity; psychosis; severe mental illness (SMI).

Publication types